Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York. more
Time Frame | ENZ | Sector | S&P500 |
---|---|---|---|
1-Week Return | -30.83% | -3.35% | -2.97% |
1-Month Return | -29.46% | -3.49% | -0.66% |
3-Month Return | -37.5% | -12.6% | 2.71% |
6-Month Return | -34.63% | -6.91% | 7.21% |
1-Year Return | -47.22% | 1.19% | 23.04% |
3-Year Return | -77.73% | -0.21% | 28.43% |
5-Year Return | -73.41% | 33.09% | 82.88% |
10-Year Return | -84.78% | 93.55% | 184.63% |
Jul '20 | Jul '21 | Jul '22 | Jul '23 | Jul '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 76.02M | 117.73M | 107.07M | 31.06M | 31.91M | [{"date":"2020-07-31","value":64.57,"profit":true},{"date":"2021-07-31","value":100,"profit":true},{"date":"2022-07-31","value":90.95,"profit":true},{"date":"2023-07-31","value":26.38,"profit":true},{"date":"2024-07-31","value":27.1,"profit":true}] |
Cost of Revenue | 52.25M | 64.15M | 65.10M | 19.50M | 17.27M | [{"date":"2020-07-31","value":80.26,"profit":true},{"date":"2021-07-31","value":98.54,"profit":true},{"date":"2022-07-31","value":100,"profit":true},{"date":"2023-07-31","value":29.94,"profit":true},{"date":"2024-07-31","value":26.53,"profit":true}] |
Gross Profit | 23.77M | 53.58M | 41.97M | 11.57M | 14.63M | [{"date":"2020-07-31","value":44.37,"profit":true},{"date":"2021-07-31","value":100,"profit":true},{"date":"2022-07-31","value":78.33,"profit":true},{"date":"2023-07-31","value":21.59,"profit":true},{"date":"2024-07-31","value":27.31,"profit":true}] |
Gross Margin | 31.27% | 45.51% | 39.20% | 37.24% | 45.86% | [{"date":"2020-07-31","value":68.18,"profit":true},{"date":"2021-07-31","value":99.24,"profit":true},{"date":"2022-07-31","value":85.47,"profit":true},{"date":"2023-07-31","value":81.2,"profit":true},{"date":"2024-07-31","value":100,"profit":true}] |
Operating Expenses | 47.41M | 48.16M | 57.47M | 31.11M | 27.00M | [{"date":"2020-07-31","value":82.49,"profit":true},{"date":"2021-07-31","value":83.79,"profit":true},{"date":"2022-07-31","value":100,"profit":true},{"date":"2023-07-31","value":54.12,"profit":true},{"date":"2024-07-31","value":46.97,"profit":true}] |
Operating Income | (23.64M) | 9.88M | (15.51M) | (24.74M) | (9.82M) | [{"date":"2020-07-31","value":-239.3,"profit":false},{"date":"2021-07-31","value":100,"profit":true},{"date":"2022-07-31","value":-156.99,"profit":false},{"date":"2023-07-31","value":-250.42,"profit":false},{"date":"2024-07-31","value":-99.38,"profit":false}] |
Total Non-Operating Income/Expense | (4.43M) | 7.19M | (3.15M) | (1.41M) | 5.89M | [{"date":"2020-07-31","value":-61.58,"profit":false},{"date":"2021-07-31","value":100,"profit":true},{"date":"2022-07-31","value":-43.85,"profit":false},{"date":"2023-07-31","value":-19.58,"profit":false},{"date":"2024-07-31","value":81.89,"profit":true}] |
Pre-Tax Income | (28.52M) | 7.88M | (18.26M) | (25.02M) | (9.82M) | [{"date":"2020-07-31","value":-362.16,"profit":false},{"date":"2021-07-31","value":100,"profit":true},{"date":"2022-07-31","value":-231.89,"profit":false},{"date":"2023-07-31","value":-317.74,"profit":false},{"date":"2024-07-31","value":-124.66,"profit":false}] |
Income Taxes | 5.37M | 4.45M | 4.32M | 12.30M | 16.26M | [{"date":"2020-07-31","value":33.02,"profit":true},{"date":"2021-07-31","value":27.37,"profit":true},{"date":"2022-07-31","value":26.55,"profit":true},{"date":"2023-07-31","value":75.63,"profit":true},{"date":"2024-07-31","value":100,"profit":true}] |
Income After Taxes | (33.89M) | 3.42M | (22.58M) | (37.32M) | (26.08M) | [{"date":"2020-07-31","value":-989.49,"profit":false},{"date":"2021-07-31","value":100,"profit":true},{"date":"2022-07-31","value":-659.21,"profit":false},{"date":"2023-07-31","value":-1089.66,"profit":false},{"date":"2024-07-31","value":-761.4,"profit":false}] |
Income From Continuous Operations | (28.52M) | 7.88M | (18.26M) | (25.02M) | (9.82M) | [{"date":"2020-07-31","value":-362.16,"profit":false},{"date":"2021-07-31","value":100,"profit":true},{"date":"2022-07-31","value":-231.89,"profit":false},{"date":"2023-07-31","value":-317.74,"profit":false},{"date":"2024-07-31","value":-124.66,"profit":false}] |
Income From Discontinued Operations | 2.08M | 2.08M | 2.08M | 45.31M | - | [{"date":"2020-07-31","value":4.59,"profit":true},{"date":"2021-07-31","value":4.59,"profit":true},{"date":"2022-07-31","value":4.59,"profit":true},{"date":"2023-07-31","value":100,"profit":true},{"date":"2024-07-31","value":"-","profit":true}] |
Net Income | (33.89M) | 3.42M | (22.58M) | 20.29M | (26.08M) | [{"date":"2020-07-31","value":-167.04,"profit":false},{"date":"2021-07-31","value":16.88,"profit":true},{"date":"2022-07-31","value":-111.29,"profit":false},{"date":"2023-07-31","value":100,"profit":true},{"date":"2024-07-31","value":-128.54,"profit":false}] |
EPS (Diluted) | (0.57) | 0.17 | (0.37) | - | (1.26) | [{"date":"2020-07-31","value":-335.29,"profit":false},{"date":"2021-07-31","value":100,"profit":true},{"date":"2022-07-31","value":-217.65,"profit":false},{"date":"2023-07-31","value":"-","profit":true},{"date":"2024-07-31","value":-743.12,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
ENZ | |
---|---|
Cash Ratio | 2.04 |
Current Ratio | 2.55 |
Quick Ratio | 2.28 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
ENZ | |
---|---|
ROA (LTM) | -7.44% |
ROE (LTM) | -14.59% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
ENZ | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.37 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.63 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
ENZ | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 1.15 |
P/B | 0.77 |
Price/FCF | NM |
EV/R | 0.26 |
EV/Ebitda | NM |
PEG | NM |
Enzo Biochem Inc (ENZ) share price today is $0.7125
Yes, Indians can buy shares of Enzo Biochem Inc (ENZ) on Vested. To buy Enzo Biochem Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ENZ stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Enzo Biochem Inc (ENZ) via the Vested app. You can start investing in Enzo Biochem Inc (ENZ) with a minimum investment of $1.
You can invest in shares of Enzo Biochem Inc (ENZ) via Vested in three simple steps:
The 52-week high price of Enzo Biochem Inc (ENZ) is $1.37. The 52-week low price of Enzo Biochem Inc (ENZ) is $0.68.
The price-to-earnings (P/E) ratio of Enzo Biochem Inc (ENZ) is
The price-to-book (P/B) ratio of Enzo Biochem Inc (ENZ) is 0.77
The dividend yield of Enzo Biochem Inc (ENZ) is 39.6%
The market capitalization of Enzo Biochem Inc (ENZ) is $36.84M
The stock symbol (or ticker) of Enzo Biochem Inc is ENZ